Voltage-gated sodium channels are important in initiating and propagating nerve impulses in various tissues, including cardiac muscle, skeletal muscle, the brain, and the peripheral nerves. Hyperexcitability of these channels leads to such disorders as cardiac arrhythmias
Introduction
Voltage-gated sodium (Na v ) channels are important in the initiation and propagation of nerve impulses in neurons and muscle (Hille, 2001) . To date, nine mammalian Na v channels have been described (Na v 1.1-1.9) (Catterall et al., 2005; Al-Sabi et al., 2006) ; these have differing distributions throughout the body. Gain-of-function mutations in Na v channels causing hyperexcitability, have been linked to such disease states as cardiac arrhythmia (Wang et al., 1995) , epilepsy (Escayg et al., 2000) , myotonia (Cannon, 1997) , and pain (Waxman et al., 1999) . Thus, there is much interest in producing subtype-selective blockers of specific Na v channel isoforms.
Venoms from fish-hunting cone snails contain many different toxins, which represent possible therapeutic compounds targeting various ion channels. -Conotoxins (CTXs) make up one such group of toxins. As a group, CTXs are identified by their conserved disulfide backbone structure and because they all target toxin site 1, in the outer pore vestibule, of Na v channels (Catterall et al., 2005) . CTXs from different species target various Na v channels and show differing selectivity profiles. CTX GIIIA from Conus geographus specifically targets skeletal muscle channels (Na v 1.4) (Cruz et al., 1985) , whereas the very similar CTX, PIIIA, from Conus purpurascens most strongly inhibits skeletal muscle channels but also blocks some neuronal channels (Na v 1.2 and Na v 1.7) with lower affinity (Shon et al., 1998) . CTX KIIIA, from Conus kinoshitai, points to the potential importance of CTXs as possible therapeutic compounds by showing analgesic activity (Zhang et al., 2007) . KIIIA is the shortest known CTX, at only 16 amino acids in length, but retains the typical CTX disulfide bond pattern (Bulaj et al., 2005) (Fig. 1 ). KIIIA has a nominal net charge of ϩ4, lower than both GIIIA (ϩ6) and PIIIA (ϩ7). It is noteworthy that KIIIA was the first CTX to show higher affinity for the neuronal channel, Na v 1.2, than for skeletal muscle channels (Zhang et al., 2007) . Indeed, KIIIA block of Na v 1.2 is almost irreversible on a normal experimental time scale. KIIIA also shows a high affinity (IC 50 in the nanomolar range) for Na v 1.7, a channel involved in pain perception (Yang et al., 2004) .
Unlike CTXs studied previously, KIIIA does not block 100% of the single-channel current (Zhang et al., 2007) . This residual single-channel current may be permitted by the absence of arginine and lysine residues in its N-terminal segment (residues 1-6), given that the PIIIA R12A derivative shows a small residual current similar to that for KIIIA (McArthur et al., 2011a) . Even though KIIIA binds to the sodium-channel pore site 1, either tetrodotoxin or saxitoxin can bind simultaneously ), increasing the range of possible pharmacological actions of KIIIA by its use in combination with the smaller pore blockers.
Here we examine differences in binding, resulting from charge-neutralizing substitutions in KIIIA, for Na v 1.2 (central nervous system), Na v 1.4 (skeletal muscle), and Na v 1.7 (peripheral nervous system). Channel mutants were selected based on sequence comparisons (Fig. 1B) and previous docking simulations of CTXs GIIIA and PIIIA (Choudhary et al., 2007; McArthur et al., 2011a) . We focused on two positions: 1) the outer ring charge in domain III, which is absent in Na v 1.7 but present in Na v 1.4 and Na v 1.2; and 2) the aromatic residue in domain I, adjacent to the DEKA locus, which has important implications for tetrodotoxin and saxitoxin block (Santarelli et al., 2007) and thus could be important in KIIIA block. These residues distinguish the canonical CTX target, Na v 1.4, from the neuronal channels Na v 1.2 and Na v 1.7. We tested the effects of changes at these loci to find how they might contribute to the observed selectivity of KIIIA among the different channel isoforms.
We show that, by substitution of individual KIIIA residues, or by altering the extracellular pH, we can change key features of KIIIA block, including maximal block, affinity and targeting selectivity. Two residues, Lys7 and Arg10, are key determinants of KIIIA's fractional block of single-channel currents, or of maximal conductance in whole-cell experiments. KIIIA's affinity, for all three Na v channels studied, increased with a decrease in extracellular pH based on increases in the toxin association rates. The increased affinity at low pH can be mostly attributed to titration of KIIIA's free N terminus. By comparison, PIIIA, with a neutral, cyclized pyroglutamate as its N-terminal residue, shows no substantial pH dependence. Changes in channel isoform targeting were seen for the KIIIA-R14A derivative, which showed 10-fold selectivity for Na v 1.7, a channel involved in the pain pathway (Yang et al., 2004; Cox et al., 2006) , over Na v 1.2 and Na v 1.4. These molecular determinants of CTX-selective targeting, offer clues to the design of more selective blockers of tissue-specific Na v channel isoforms. with important residues highlighted (Lys7, cyan; Arg10/Arg14, blue; His12, purple). B, sodium-channel sequence alignment of the domains I and III p-loop regions, with inner ring (blue) and outer ring (red) labeled. Sequences of channel mutants rNa v 1.4 Y401F, rNa v 1.4 D1241I, and hNa v 1.7 D1241I are shown.
Materials and Methods
Toxin Synthesis and Preparation. Conotoxin synthesis, purification, and disulfide bond formation were performed as described previously in detail (Hui et al., 2002) . In brief, linear peptides were synthesized by solid-phase synthesis using 9-flurenylmethoxycarbonyl chemistry. Coupling of 9-flurenylmethoxycarbonyl amino acids was performed using the 1-hydroxybenzotriazole/2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate/N,N-diisopropylethylamine method on a Quartet Synthesizer (Protein Technologies Inc., Tucson, AZ).
Crude linear peptide was subjected to oxidative folding under equilibrating condition (i.e., air oxidation in ammonium acetate buffer, pH ϳ7.6, in the presence of a small amount of mercaptoethanol (10 l in 150 ml) to promote the formation of the most stable disulfide bonds. During oxidization, the cyclization of the peptide was monitored by analytical HPLC, which was completed in 2 to 4 days at 4°C. The crude cyclized peptide showed a single major peak on analytical HPLC, with some minor peaks being seen in each case (the number and size of minor peaks varied with the derivative being cyclized). The crude cyclized peptide was then isolated from the acidified reaction mixture by reversed-phase extraction, was purified to near homogeneity by HPLC, and the identity of the purified peptide was confirmed by matrixassisted laser desorption ionization mass spectrometric molecular weight determination. Some derivatives produced two separate peaks, and thus the peak identified as active by Zhang et al. (2007) was used.
Lyophilized conotoxin derivatives were then dissolved in the bath solution to an appropriate stock concentration. Toxin solutions used in the experiments were further diluted in the bath solution to the required concentration.
Sodium Channel Expression in HEK293 Cells. Mammalian expression plasmids encoding rNa v 1.2 (pCDM8, a gift from W. A. Catterall) (Linford et al., 1998) , rNa v 1.4 (pcDNA3.1) (Trimmer et al., 1989) , and hNa v 1.7 (pCMV6) (Hildebrand et al., 2011) were used. Channel constructs were created using rNa v 1.4 or hNa v 1.7 as a template. Three channel mutants (rNa v 1.4 Y401F, rNa v 1.4 D1241I, and hNa v 1.7 I1410D) were constructed. In brief, sense and antisense primers encoding point mutations for the desired amino acid substitution were synthesized and used in high-fidelity PCRs (Phusion polymerase; Thermo Fisher Scientific, Waltham, MA) with primers located either 3Ј or 5Ј, respectively, from unique flanking restriction sites in the wild-type construct. Amplified fragments (upstream and downstream) were run on agarose gels, and the resulting products were isolated, mixed, and subjected to another round of high-fidelity PCR using only the 3Ј and 5Ј primers. The resulting product was purified, digested with the appropriate restriction endonucleases, and cloned into like-digested wild-type channel clones. All fragments cloned from PCR products were completely sequenced to ensure no PCR-generated misincorporations had occurred during cloning.
HEK293 cells were transiently cotransfected with the plasmid encoding the particular sodium channel ␣-subunit (2 g) and a plasmid encoding green fluorescent protein (0.5 g), allowing transfected cells to be identified by their green fluorescence. Twenty-four hours after transfection, cells were plated on to coverslips and used for voltage-clamp studies at least 2 h after plating.
Electrophysiology. Sodium channel currents were recorded by the patch-clamp technique in the whole-cell configuration at room temperature (23-25°C). The bath solution contained 140 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, and 10 mM glucose, adjusted to pH 6, 7.4, or 9 with HCl or NaOH (ϳ305 mOsmol/kg). The pipette electrodes had a final tip resistance of 1 to 3 M⍀ with an internal solution composed of 35 mM NaCl, 105 mM CsF, 1 mM MgCl 2 , 10 mM HEPES, and 1 mM EGTA, with pH adjusted to 7.2 with CsOH (ϳ295 mOsmol/kg).
Whole-cell patch clamp was performed with an EPC7 Amplifier (HEKA, Lambrecht/Pfalz, Germany). Current traces were filtered at 3 kHz (low-pass, three-pole Bessel filter, EPC7) and sampled at 200 kHz using pClamp9.2 software (Molecular Devices, Sunnyvale, CA), with series resistance compensated typically at 40 to 60%. Cells showing peak currents between 0.5 and 5 nA were used to ensure adequate voltage control while maintaining good current resolution. Toxins were then locally superfused over the cell at a rate of 10 to 20 l/min (bath volume of 5 ml). Currents were elicited with a 2-s prepulse to Ϫ140 mV to remove inactivation followed by a test pulse to Ϫ10 mV for 10 ms repeated every 5 s during toxin application and washout to record kinetics. Single-channel bilayer experiments using batrachotoxinmodified skeletal muscle Na v channel at steady state were carried out as described previously (McArthur et al., 2011a) .
Data Analysis. Each point data point on a dose-response curve was from data for one toxin-containing solution applied to a single cell, with control data taken before and after toxin application on the same cell. Overall, 27 dose-response curves were generated using 6 different channel constructs, and 6 toxin derivatives, with 18 Ϯ 4 experiments contributing to each dose-response curve. Typically three to four determinations were done at each concentration (range, 1-9). Dose-response curves are plotted as the estimated fraction of channels blocked Fb ss ϭ (1 Ϫ I tx /I ctr ) versus concentration of toxin, where I tx is the residual current in the presence of the toxin at steady state and I ctr is the current level before toxin application. Data were fit with a rectangular hyperbola, assuming a Hill coefficient of 1, using the following expression, where IC 50 is the toxin concentration for half-maximal inhibition. Here, Fb ss is the fraction of current blocked by the toxin at steady state, at a particular concentration, and Fb sc represents the maximal fraction of current blocked at saturating concentrations of the toxin (and the fractional block of the single-channel current). The parameters Fb sc and IC 50 were varied to obtain the best fit.
Toxin blocking kinetics (k on and k off ) were measured by fitting the peak currents for successive depolarizations during toxin wash-in or wash-out test with a single exponential to determine on and off . The rates constants, k on and k off , and the equilibrium dissociation constant, K d (Fig. 2, A and B) were calculated using the following equations:
For ease of reading in the text, group data are represented as mean values, with full statistics provided in the tables. Differences between group data sets were considered significant if p Ͻ 0.05 in an unpaired t test, unless otherwise stated.
Molecular Dynamics Simulations. Molecular dynamics (MD) simulations of the docking of CTX KIIIA (Bulaj et al., 2005) to a sodium channel model (Choudhary et al., 2007) were performed as described previously (McArthur et al., 2011b) . In brief, MD simulations were carried out using the GROMACS set of programs (Berendsen et al., 1984; Lindahl et al., 2001 ) using the AMBER 99 force field. At first, KIIIA was superposed on to the docked structure of GIIIA. Ten simulations of 20 ns were run, and the resulting structures were aligned with respect to the channel backbone using a least-squares fit and clustered using the g_cluster program (Daura et al., 1999) , with a root mean square deviation cutoff of 0.4 nm. The top cluster incorporated Ͼ60% (2818) of all the structures (4501), and the center of the cluster was chosen to represent the toxin-bound conformation. All visualization of molecules was carried out using visual MD (Humphrey et al., 1996) .
Results
Charged residues play critical roles in defining how CTXs target and block Na v channels. Despite KIIIA being shorter than both PIIIA and GIIIA, the charged residues in the C-terminal segment are highly conserved across the three toxins despite their differences in Na v channel selectivity (Fig. 1) . To identify residues that might be involved in iso- form selectivity, we neutralized all basic residues in KIIIA by replacing them with alanines (KIIIA-K7A, R10A, H12A, and R14A) and synthesized a KIIIA derivative, which lacks the N-terminal charge (KIIIA-DA, des-amino). Whole-cell voltage-clamp recordings were used to determine the kinetics of toxin block of Na v 1.2, 1.4, and 1.7. The toxin substitutions altered toxin binding and unbinding kinetics, as well as the maximal block at saturating toxin concentrations, to varying Fig. 2 . KIIIA-R14A selectivity profile is altered compared with KIIIA-wt. A, example experiment of KIIIA-wt (1 M) wash-in in Na v 1.4. B, example washout experiment of KIIIA-wt (1 M) from same cell as A. C and D, dose-response curves for KIIIA-wt (data from 96 cells) and KIIIA-R14A (data from 96 cells) in Na v 1.2, Na v 1.4, Na v 1.7, Na v 1.4 D1241I, and Na v 1.7 I1410D, respectively. Note that the curve for Na v 1.2 and KIIIA-wt in part C, was forced through the kinetically determined K d (E), because the time constant block was too long near this concentration to reliably attain steady-state block. In other cases, both IC 50 and the maximal saturating block, Fb sc were determined directly from fits to the steady-state dose-response data. E, comparison of IC 50 values for KIIIA-wt and KIIIA-R14A in each channel. degrees in the three channel subtypes. To assess the importance of differences among the channels, we used the following constructs: Na v 1.4 Y401F, Na v 1.4 D1241I, and Na v 1.7 I1410D. These represented the major differences, among the three channels, located near the inner and outer ring charges (Fig. 1B) . Unlike previous studies with the larger CTX GIIIA (Li et al., 2001 (Li et al., , 2003 Cummins et al., 2002) , which found residues in the domain II turret region to be important in toxin selectivity, we focused on residue differences around the inner and outer ring residues, in part because of KIIIA's smaller size and lower net charge.
Block of Na v 1.2, 1.4, and 1.7 by Wild-Type KIIIA. Channel isoforms Na v 1.2, 1.4, and 1.7 were expressed heterologously in HEK293 cells, and currents were recorded using the whole-cell patch-clamp technique at pH 7.4. Kinetics of block by KIIIA-wt were determined from whole-cell currents elicited by repeated depolarizing steps (Fig. 2, A and B) . KIIIA blocked Na v 1.2 with the highest affinity (K d ϭ 5 nM) compared with Na v 1.4 (K d ϭ 37 nM) and Na v 1.7 (K d ϭ 97 nM) (Table 1) . Dose-response curves are plotted in Fig. 2C . As shown in the dose-response curves, all three channels showed similar maximal block levels (Na v 1.2, 90%; Na v 1.4, 95%; and Na v 1.7, 94%) at saturating concentrations of wildtype KIIIA. Kinetics are very slow in Na v 1.2, making it impractical to collect truly steady-state data. Thus, this doseresponse curve was fit using an IC 50 of 5 nM, equal to the kinetically determined K d . Other cases provided steady-state data, which allowed direct determination of IC 50 values from the dose-response relation, and these values correspond well with K d , values determined from the kinetics. Overall, wildtype KIIIA (KIIIA-wt) shows a range of binding affinities of ϳ30-fold in the following order: Na v 1.2 Ͼ Na v 1.4 Ͼ Na v 1.7 (IC 50 /K d values: 5, 54, and 147 nM, respectively).
The underlying differences in binding and unbinding kinetics are shown in Table 1 . Na v 1.2 and Na v 1.7 had slow association rates, k on (0.28 and 0.18 M Ϫ1 ⅐ min Ϫ1 , respectively) relative to that of Na v 1.4 (1.6 M Ϫ1 ⅐ min Ϫ1 ). The dissociation rate constants, k off , also differed among channel isoforms with Na v 1.2 being the slowest (0.002 min Ϫ1 ) followed by Na v 1.7 (0.017 min Ϫ1 ) with Na v 1.4 being the fastest (0.060 min Ϫ1 ). These indicate that the toxin-channel complex has a longer mean lifetime for the neuronal channels, Na v 1.2 and Na v 1.7, than for the skeletal muscle isoform, Na v 1.4. These relationships are reminiscent of previously reported data from studies in Xenopus laevis oocytes (Zhang et al., 2007) . Despite the skeletal muscle targeting for which the CTX family is named, KIIIA shows its highest affinity for the brain channel Na v 1.2.
Substitution R14A in KIIIA Changes Its Target Specificity. Replacement of KIIIA's arginine-14 with alanine removed a basic side chain resulting in the derivative KIIIA-R14A, which is selective for Na v 1.7 over both Na v 1.2 and Na v 1.4 (IC 50 values 0.36, 3.7, and 6.8 M, respectively; see Fig. 2D ). KIIIA-R14A showed a slightly decreased k on but unchanged k off values (Table 1) in its interaction with Na v 1.7 (0.038 M Ϫ1 ⅐ min Ϫ1 and 0.020 min Ϫ1 , respectively). In contrast, for Na v 1.2 and Na v 1.7, there were changes in both k on and k off , with k on getting slower (0.024 and 0.21 M Ϫ1 ⅐ min Ϫ1 for Na v 1.2 and 1.4, respectively), and k off (0.026 and 1.2 min Ϫ1 for Na v 1.2 and 1.4, respectively) getting faster for both. Despite the changes in affinity there were no significant changes in maximal block compared with KIIIA-wt (range, 87-91%; see Table 1 ). Here, the dramatic result is that the peripheral nerve channel isoform, Na v 1.7, becomes the preferred target for KIIIA R14A by a factor of 10-to 20-fold over Na v 1.2 and Na v 1.4.
Channel Residues in the Domain III Outer Ring Interact with KIIIA-R14A. Two channel mutants were constructed to look at the effects of the domain III outer ring charge on KIIIA-R14A's binding. Based on previous studies of other -conotoxins (Choudhary et al., 2007; McArthur et al., 2011a) , it seemed likely that KIIIA's Arg14 should interact with residues in domain III and IV near the outer ring charges. To explore the basis for the observed differences we scanned for sequence differences among Na v 1.2/1.4 and Na v 1.7 in these domains (Fig.  1B) . In human Na v 1.7, an isoleucine (Ile1410) is present at the "outer ring" position of domain III, taking the place of the aspartate found in all other Na v channels (Asp1241 in rat Na v 1.4). Thus, we constructed two "exchange" mutants, rNa v 1.4 D1241I and hNa v 1.7 I1410D, to test for possible interactions with Arg14 in KIIIA.
First, we tested KIIIA-wt on both channels to determine whether this exchange could explain the differences in affinity between Na v 1.4 and Na v 1.7 for KIIIA-wt ( Fig. 2C ; Table  1 ). The Na v 1.4 D1241I mutation increased the K d of wildtype KIIIA to 102 nM (close to that of Na v 1.7, 97 nM), whereas the Na v 1.7 I1410D mutation decreased the K d to 56 nM (similar to that of Na v 1.4, 37 nM). The mutations had opposite effects on the k on and k off rates. The Na v 1.4 D1241I mutation slowed the association rate and sped up the disso- ciation rate, compared with KIIIA-wt block of Na v 1.4, accounting for the observed lower affinity of the mutant channel. In turn, Na v 1.7 I1410D showed an increased association rate, with little change in the dissociation rate, leading to the observed higher affinity of the mutant channel. Next, we looked at block of the two channel mutants by KIIIA-R14A (Fig. 2D) . In both cases compared with KIIIA-R14A's block of native Na v 1.4 and Na v 1.7, there was little change in the parameters k on , k off , and K d . The on and off rates for Na v 1.4 D1241I were not significantly different from native Na v 1.4. The Na v 1.7 I1410D mutant showed slightly increased values of both k on and k off . These changes yielded the observed small differences in K d (3.7 and 5.7 M between Na v 1.4 and Na v 1.4 D1241I, and 0.51 and 0.78 M for Na v 1.7 and Na v 1.7 I1410D, respectively; see Table 1 ).
The Na v 1.4 D1241I mutation had no effect on the maximal block by KIIIA-wt (98%), but the Na v 1.7 I1410D mutation decreased KIIIA-wt's maximal block to 59% (Fig. 2C) . With KIIIA-R14A, the Na v 1.4 D1241I mutation induced no significant change in maximal block (94%) compared with Na v 1.4, whereas the Na v 1.7 I1410D decreased the maximal block level to 64% compared with native Na v 1.7 (Fig. 2D) .
General implications for binding affinity that emerge of these experiments are that 1) the differences of binding of KIIIA-wt among Na v 1.4, Na v 1.7, and their reciprocal mutants depend on the presence or absence of an interaction between toxin Arg14 and the domain III outer ring aspartate; and 2) the substitution R14A removes this interaction, so that subsequent replacement of the outer ring aspartate has little influence (affinities for each parent channel and its respective mutant are essentially equal; see Fig. 2E ).
Substitution K7A Affects Both the Affinity and Maximal Block. Neutralization of lysine-7 in KIIIA lowers the toxin's affinity for all three channel isoforms, but the K7A derivative has the same selectivity profile as KIIIA-wt (Na v 1.2 Ͼ Na v 1.4 Ͼ Na v 1.7) (Fig. 3A) . KIIIA-K7A has a similar effect on IC 50 in all three channels in that it decreases affinity ϳ30-fold for all three channel isoforms (Tables 1 and 2 ). The effects on affinity are mostly due to increases in k off (11-to 20-fold), with small decreases in k on (1.5-to 3-fold). Removal of the Lys7 charge decreased the maximal block of the toxin compared with KIIIA-wt. In Na v 1.2 the maximal block was 68%, which was larger than both Na v 1.4 and Na v 1.7 (60 and 58%, respectively) (Fig. 3B) . Examining a similar CTX, PIIIA, a similar decrease in residual current is seen in Na v 1.2 compared with Na v 1.4 and Na v 1.7, at the homologous position (PIIIA-R14A; see Fig. 3, C and D) , suggesting a similar bound orientation of this residue.
A Tyrosine/Phenylalanine Substitution in Domain I Modulates the Maximal Block by KIIIA-K7A. From previous studies of -conotoxins, we expected that Lys7 would face down into the pore and would interact predominantly with residues in domain I and II. We scanned the pore regions of Na v 1.2, 1.4, and 1.7 in these two domains and found that Na v 1.4 and Na v 1.7 have a conserved tyrosine one residue external to DEKA locus in domain I, whereas Na v 1.2 has a phenylalanine at this position. To test for a role for this residue in determining maximal block by KIIIA-K7A in Na v 1.2 versus Na v 1.4 and 1.7, we generated a Na v 1.4 Y401F mutant. The Na v 1.4 Y401F mutant showed a maximal block of 69%, significantly larger than Na v 1.4 and 1.7 and the same as Na v 1.2 (Fig. 3, A and B) . When PIIIA-R14A was tested in the Na v 1.4 Y401F construct, The residual current was reduced to the same level as the native Na v 1.2 residual current level (Fig. 3, C and D) . This mutation had little effect on either the IC 50 values or the kinetics compared with native Na v 1.4. In contrast, the Na v 1.4 D1241I outer ring mutation did not affect the maximal block by KIIIA-K7A ( Supplementary Fig. 1 ).
Neutral Replacement of Arg10 Decreases Affinity and Maximal Block of KIIIA. Replacement of Arg10 with an alanine in KIIIA increases the IC 50 of the toxin for all three channel isoforms (ϳ14-to 97-fold) yet retains the KIIIA-wt isoform specificity profile of Na v 1.2 Ͼ Na v 1.4 Ͼ Na v 1.7 (Fig. 4A) . The decreases in affinity result from decreases in k on (2-to 4-fold), and increases in k off (3-to 11-fold; see Table 3 ).
The maximal block of KIIIA-R10A is reduced compared with KIIIA-wt in all three channel isoforms. The largest reduction was seen for Na v 1.7, to 52%, whereas reduction of Na v 1.2 to 66% and Na v 1.4 to 70% showed similar maximal block levels.
We looked at the effects of KIIIA-R10A in the domain III channel mutants, Na v 1.4 D1241I and Na v 1.7 I1410D. The Na v 1.4 D1241I mutant did not significantly affect the IC 50 of KIIIA-R10A, whereas the Na v 1.7 I1410D only slightly increased the IC 50 (Ͻ4-fold). For Na v 1.4 D1241I and Na v 1.7 I1410D, there were small decreases in both the k on (ϳ2.5-fold) and k off (6-fold), respectively, compared with their respective native channels (Tables 1 and 3 ). Both channel mutants showed increased maximal block with KIIIA-R10A, to 93% for Na v 1.4 D1241I and 77% for Na v 1.7 I1410D.
Substitution H12A Decreases KIIIA Affinity by Increasing Dissociation Rate and Modifies Specificity. Substitution of His12 with an alanine severely reduced the affinity of the toxin for all native channel isoforms (Fig. 4B) . This substitution increased the IC 50 values for Na v 1.2 and Na v 1.4 by Ͼ2000-fold, whereas in contrast, the increase in IC 50 for Na v 1.7 was only 133-fold (Fig. 4B) . The resulting sequence of affinities for KIIIA-H12A was Na v 1.2 Ͼ Na v 1.7 Ͼ Ͼ Na v 1.4. These drastic changes in affinity were not due to changes in k on (2--6-fold decreases) but rather to changes in k off , 1.4 (700-fold increases), 30.4 (500-fold increase), and 2.0 min Ϫ1 (120-fold increase), for Na v 1.2, 1.4, and 1.7, respectively). Maximal block by KIIIA-H12A was slightly reduced in all three channels (to Fig. 4 . Substitutions in KIIIA decrease maximal block (R10A), and binding affinity (H12A). A, dose-response curves for KIIIA-R10A (data from 89 cells) block of Na v 1.2, Na v 1.4, Na v 1.7, Na v 1.4 D1241I, and Na v 1.7 I1410D. Maximal block ranges from ϳ0.5 to ϳ0.9. B, dose-response curves of KIIIA-H12A (data from 89 cells) for Na v 1.2, Na v 1.4, and Na v 1.7. IC 50 values are ϳ1000-fold larger than for KIIIA wt for the same channel isoforms. C, batrachotoxin-modified, single-channel currents showing KIIIA-H12A blocked levels (red arrow; black dotted line denotes fully closed level) of rat skeletal muscle sodium channels (Na v 1.4). Given the low affinity of H12A, it was not possible to use high enough concentrations to determine maximal block from whole-cell dose-response data; in the single-channel recordings, the blocked fraction, with H12A bound, was ϳ0.8. This value was used to constrain the fit of the dose-response curve for Na v 1.4 in B. Fractional block at saturating toxin concentrations (Fb sc ) are determined from the dose-response curves in Fig. 3 . 81% for Na v 1.2, 78% for Na v 1.4, and 88% for Na v 1.7). For Na v 1.4, given the very low affinity, the maximal block was estimated from single-channel recordings using lipid bilayers (Fig. 4C) .
Binding of KIIIA Is Enhanced at Low pH Based on Increased Association Rates. To examine the effects protonation on KIIIA-wt block, we measured the kinetics of toxin binding and unbinding at pH 6.0, 7.4, and 9.0. An example of the effects of pH on KIIIA-wt block of Na v 1.4 is shown in Fig. 5A . Increasing the pH caused a decrease in k on in Na v 1.2, 1.4, and 1.7 (Fig. 5C ). For Na v 1.2, the k on decreased from 2.2 M Ϫ1 ⅐ min Ϫ1 at pH 6.0 to 0.28 M Ϫ1 ⅐ min Ϫ1 at pH 7.4, and to 0.053 M Ϫ1 ⅐ min Ϫ1 at pH 9.0. Similar to Na v 1.2, the channels Na v 1.4 and Na v 1.7 also showed decreases in k on as the pH was increased (Fig. 5C ). On average, across the three channel isoforms, k on decreased 13-fold per pH unit over the pH range from 6.0 to 9.0.
The effects of pH on k off were less pronounced (Fig. 5D ). In Na v 1.2, there was no significant difference in k off between pH 6.0 and 7.4 (0.004 and 0.002 min Ϫ1 , respectively), whereas Na v 1.4 showed a slight decrease in k off from pH 6.0 to 7.4 (0.11 and 0.060 min Ϫ1 , respectively). However, from pH 6.0 or 7.4 to 9.0, both Na v 1.2 and Na v 1.4 showed an increase in k off (to 0.010 and 0.43 min Ϫ1 , respectively). For Na v 1.7 there was no significant changes in k off across all three pH values (0.012, 0.017, and 0.015 min Ϫ1 , respectively). The strong influence of pH on k on , combined with its minimal influence on k off , resulted in a decreased affinity as pH increases. As a consequence, for KIIIA-wt block of Na v 1.2, the K d increased by ϳ90-fold from 2 to 183 nM, from pH 6.0 to 9.0. Similar results were seen for Na v 1.4 and Na v 1.7 (Fig.  5E) . Even in the absence of a free N-terminal amino group (see below), there is sufficient residual pH sensitivity to see a monotonic increase in K d in the range of pH 6 to 9.
Removal of the Charged Amine at the KIIIA N terminus Strongly Attenuates pH Dependence. To learn the basis of the pH effects on k on , we constructed a toxin derivative lacking the titratable N-terminal amino group desamino KIIIA (KIIIA-DA) and tested the effects of changes in pH on its kinetics (Fig. 5B, gray) . There was a reduced sensitivity of k on to pH for all the native channels (Fig. 5C ). These changes, averaged over the three channel isoforms, reflect a decrease in k on of 1.7-fold per pH unit (approximately 13-fold for KIIIA-wt) over the pH range from 6.0 to 9.0 (see above).
Similar to the effects of pH on wild-type KIIIA's k off , pH has little effect on KIIIA-DA's k off . In Na v 1.2, there was no significant difference in k off across pH (0.025, 0.014, and 0.018 min Ϫ1 for pH 6.0, 7.4, and 9.0, respectively) (Fig. 5D ). However, in both Na v 1.4 and Na v 1.7, there is a significant difference between pH 7.4 and 9.0 (0.10 and 0.48 min Ϫ1 for Na v 1.4 and 0.016 and 0.063 min Ϫ1 for Na v 1.7). The reduced pH effect on KIIIA-DA's k on compared with KIIIA-wt, leads to a smaller increase in K d as pH is increased. In Na v 1.2, the K d increases from 162 nM at pH 6.0 to 186 nM at pH 7.4 and to 635 nM at pH 9.0 (Fig. 5E ). Similar to these results, Na v 1.4 and Na v 1.7 also increase in K d from pH 6.0 to 7.4 to 9.0 (199 nM, 294 nM, and 3.2 M for Na v 1.4 and 145 nM, 558 nM, and 5.5 M for Na v 1.7, respectively). Double Mutant Cycle Analysis and Molecular Dynamics Simulations of -CTX KIIIA-Bound Structure. The KIIIA structure was overlaid on the GIIIA docked conformation generated previously (Choudhary et al., 2007) , and MD simulations were run for 20 ns. The toxin backbone was stable within an average root mean square deviation of 1.5Å. The largest cluster contained Ͼ60% of all the structures calculated. Its central structure is shown in Fig. 6A (green backbone), along with the starting structure (purple backbone). In this structure, Lys7 points toward the outer ring charges of domain I and II, whereas the Arg10 lies close to the domain I outer ring glutamate. Arg14 interacts with the outer ring charges in both domains III and IV, whereas the His12 lies between the outer ring charges of domains II and III.
We performed double mutant cycle analysis for toxin/channel pairs of KIIIA-Lys7 with Na v 1.4 Tyr401 and Asp1241, and for both KIIIA-Arg10 and KIIIA-Arg14 with Na v 1.4 Asp1241 and Na v 1.7 Ile1401 ( Fig. 6D ; Supplementary Table  1) . KIIIA-Lys7 showed no substantial coupling to Na v 1.4 Tyr401 (0.27 kT), and only a small coupling (1.0 kT) to the outer ring domain III charge, Na v 1.4 Asp1241. The KIIIA-R10A and R14A derivatives both showed larger couplings than KIIIA-K7A, of 1.5 kT or greater, to the domain III outer ring charge (Na v 1.4 Asp1241). Experiments with hNa v 1.7 and its reciprocal outer ring mutation (I1410D) showed increased affinity for KIIIA-wt (Fig. 2E) , whereas mutant cycle analysis showed similar or slightly greater coupling energies to those obtained with rNa v 1.4. Thus, these two sets of data confirm that residues Arg10 and Arg14 of KIIIA are both interacting partners with the domain III outer ring position on the channel.
Discussion
Differing Kinetics of KIIIA Block among Na v Isoforms from Brain, Skeletal Muscle, and Peripheral Nerve. Wild-type KIIIA is selective among channel isoforms, Fractional block at saturating toxin concentrations (Fb sc ) is determined from dose-response data in Fig. 4 . Toxin (KIIIA) and Channel as reflected by mean IC 50 values for Na v 1.2 (5 nM, brain) over Na v 1.4 (37 nM, skeletal muscle) and Na v 1.7 (97 nM, peripheral nerve). Underlying the differences in affinity are changes in both binding and unbinding kinetics. The high affinity for Na v 1.2 is due predominantly to extremely slow dissociation (k off , 0.002 min Ϫ1 ), making it irreversible for 50 but has the most divergent kinetics of the three. Its k on is 6-to 9-fold faster (1.6 M Ϫ1 ⅐ min Ϫ1 ) than those for both of the neuronal channels, but it also has the fastest k off (0.060 min Ϫ1 ). The faster kinetics in Na v 1.4 may reflect an evolutionary adaptation allowing the snail to rapidly immobilize its prey by blocking skeletal muscle action potentials (Table 1; Fig. 5C ).
Compared with CTX GIIIA and PIIIA, CTX-KIIIA's higher affinities for both neuronal channels examined arise from a much slower dissociation rate. KIIIA's dissociation from Na v 1.2 is ϳ100-fold slower than that of PIIIA, whereas the association rate constants are not significantly different (McArthur et al., 2011a) .
Derivative KIIIA-R14A Selectively blocks Na v 1.7, an Important Contributor to Pain Signaling. Unlike KIIIA-wt (affinities in the sequence Na v 1.2 Ͼ 1.4 Ͼ 1.7), KIIIA-R14A is selective for Na v 1.7 over both Na v 1.2 and Na v 1.4. The R14A substitution yielded a much less pronounced decrease in K d for Na v 1.7 (ϳ5-fold) than for Na v 1.2 (200-fold) and Na v 1.4 (150-fold), suggesting that 14 lacks the strong interaction with Na v 1.7 that occurs with both Na v 1.2 and Na v 1.4. Sequence alignment (Fig. 1A) shows this residue to be analogous to Arg19 in GIIIA and Arg20 in PIIIA. From MD docking simulations, we expected KIIIA-Arg14 to interact with the outer ring charges of domains III/IV for Na v 1.2 and Na v 1.4. However, the sequence alignment (Fig. 1B) shows that in hNa v 1.7, isoleucine replaces the outer ring aspartate that is present in domain III for both Na v 1.2 and Na v 1.4. The lack of this aspartate seems to account for the smaller change in affinity for Na v 1.7 associated with the KIIIA-R14A substitution.
The DIII outer ring reciprocal mutants (Fig. 1B) in Na v 1.4 D1241I and Na v 1.7 I1410D reveal a clear basis for the different affinities of KIIIA-wt for these two channels (Fig. 2E) . The Na v 1.4 D1241I mutation increased the K d to 102 nM, approximating that seen for Na v 1.7 (97 nM), whereas the reciprocal mutation (Na v 1.7 I1410D) mutation decreased the K d to 56 nM, closer to that for Na v 1.4 (37 nM). Consistent with this, KIIIA-R14A showed very similar K d values for the wild-type and mutant channel pairs (5.7 and 3.7 M for Na v 1.4 and Na v 1.4 D1241I, versus 0.51 and 0.78 M for Na v 1.7 and Na v 1.7 I1410D). This suggests that the DIII outer ring charge and Arg14 are interacting partners in toxin binding (see Fig. 6D and Supplementary Table 1 for coupling energies calculated from mutant cycle analysis).
Residues on Both Toxin and Channel Modulate Current through Toxin-Bound Channels. KIIIA-wt was the first native CTX shown to allow a residual single channel current (5-10%) when the toxin is bound (Zhang et al., 2007) . This current can be eliminated when guanidinium toxins such as tetrodotoxin or saxitoxin are applied after KIIIA is bound. Simultaneous binding of a KIIIA derivative and one of the guanidinium toxins modifies blocking and unblocking kinetics and opens a wider spectrum of pharmacological possibilities than the use of either type of toxin individually French et al., 2010) .
The two KIIIA residues that strongly modulate maximal block (Lys7 and Arg10) are analogous to Arg14 and Lys17 in Fig. 6 . Molecular dynamics docking simulations and estimates of some toxin-channel coupling energies. A, starting (purple) and docked (green) structures of KIIIA with individually colored channel domains (domain I, ice blue; domain II, orange; domain III, yellow; domain IV, brown). B, space-filled docked structure of KIIIA, highlighting the amino acids studied. C, toxin backbone (green) with basic residues (space-filled) and with DEKA ring (liquorice stick format) residues highlighted. In the experiments, each of the toxin residues labeled, was either replaced by a neutral substitution, or titrated (-NH 2 terminal), to change the charge at that position. D, coupling energies, expressed as kT (where k is the Boltzmann constant and T is temperature in degrees Kelvin) and given as unsigned, absolute values, calculated from double mutant cycle analysis for interactions between toxin/channel residue pairs. The strongest couplings were found with channel domain III, pore outer ring position (see Fig. 1 ).
PIIIA, where neutral substitutions enable similar residual currents (McArthur et al., 2011a) . Furthermore, KIIIA-wt, which is six amino acids shorter than PIIIA, lacks a charged residue analogous to PIIIA-Arg12, suggesting that the observed residual current for KIIIA-wt could result from the lack of this charge.
KIIIA-K7A, shows the lowest degree of maximal block at saturating toxin concentrations, and this level is Na v channel isoform-specific (Fig. 3A) . From previous work, we expected Lys7 to interact with domain I and domain II between the inner and outer rings. Sequence alignment (Fig. 1B) shows a tyrosine adjacent to the inner ring for both Na v 1.4 and 1.7, in which Na v 1.2 has a phenylalanine. The mutation Na v 1.4 Y401F had little effect on the K d of KIIIA-K7A but increased the maximal block to 69%, near that for Na v 1.2. This suggests that with KIIIA-K7A bound, ion passage through the channel is limited by Tyr401, which is a primary determinant of tetrodotoxin and saxiton affinity (Favre et al., 1995) .
The KIIIA-R10A substitution also modulates maximal block. With R10A, maximal block is ordered as follows: Na v 1.7ϽNa v 1.2ϽNa v 1.4, likely as a result of the differences in domain III, where Na v 1.7 has an isoleucine, whereas Na v 1.2 and Na v 1.4 each have an aspartate.
The key new point here is that residues from both toxin and channel help to determine the toxin efficacy by controlling the maximal block. A full analysis of the chemical and steric factors involved will require extensive substitutions in both toxin and channel, taking advantages of general approaches developed earlier (Hui et al., 2002) and could reveal additional opportunities for pharmacological approaches using KIIIA derivatives in combination with other ligands French et al., 2010) .
His12 of KIIIA Contributes Strongly to Binding to All Three Channel Isoforms. A conserved histidine (His12 in KIIIA) is found in CTXs, which block both neuronal and skeletal muscle channels. In PIIIA, replacement of this residue by glutamine increased the affinity of PIIIA for skeletal muscle Na v 1.4 channels over neuronal Na v 1.2 (McArthur et al., 2011a) . The KIIIA-H12A substitution severely reduced toxin affinity, primarily based dramatic increases in the dissociation rates (700-, 500-, and 120-fold increase in Na v 1.2, 1.4, and 1.7, respectively). This contrasts strongly with PIIIA, for which H19Q caused no reduction in affinity (McArthur et al., 2011a ). KIIIA's smaller size and net charge may allow the histidine to play a more dominant role. The H12A-associated reductions in affinity were dramatic and result in preferential targeting of the two neuronal isoforms, Na v 1.2 and Na v 1.7, over skeletal muscle Na v 1.4 (Fig. 4B) . Of the toxin derivatives that we studied, only H12A and R14A showed a clear change in channel isoform targeting preference from that of KIIIA-wt.
Protonation of KIIIA Increases Association Rate and Hence Affinity. Changing pH in the range of 6 to 9 produced obvious, systematic increases in k on values as pH decreased, showing an average change of 13-fold per unit pH over the three channel subtypes, with little change in k off (Ͻ3-fold). Thus, the large effect of the H12A substitution on dissociation rates rules out His12 as the primary mediator of pH effects. Furthermore, the parallel effects of pH on the three different channel isoforms make it unlikely that the major effect is mediated through titration of acidic residues in the channels' outer vestibules.
An alternate possibility is that a disulfide linkages in the toxin could be lost at higher pH. However, removal of only one of the three disulfide linkages yielded a lower k on the C2-C15 linkage (Han et al., 2009; Khoo et al., 2009 ). This decrease in k on fits with the KIIIA-wt pH results, the concomitant 10-fold increase in k off , together with the rapid reversibility of our observed pH effects, makes disulfide bond disruption an unlikely rationale for our observations.
A third possibility is that KIIIA's free N terminus could be titrated by the changing pH, and indeed, this clearly affects the observed toxin kinetics. An examination of differences between the PIIIA and KIIIA structures supports this interesting possibility, because PIIIA block shows no dependence on pH (data not shown), and PIIIA lacks a free N-terminal charge as the residue is cyclized to form a pyroglutamate. Thus, we created a KIIIA derivative lacking the free N-terminal charge, KIIIA-DA. This derivative showed a reduced pH dependence from 13-fold to 1.7-fold change per pH unit. Consequently, the observed pH dependence of KIIIA block is due predominantly to titrating its free N-terminal charge, with the remaining dependence perhaps arising from the Asp11-His12 pair. This raises a possible complication for the strategy of toxin cyclization as a way of stabilizing the active conformation (Clark et al., 2010) . If protonation of the free amino terminal were important for a pharmacological action, this option would be lost in the N-terminal to C-terminal cyclized version.
Possible Pharmacological Applications of KIIIA Derivatives. Na v 1.7 plays a role in pain signaling. Gain of function mutations lead to primary erythermalgia (Yang et al., 2004) , whereas loss of function leads to congenital inability to experience pain (Cox et al., 2006; Fertleman et al., 2006) , prompting a renewed interest in finding subtype selective blockers of hNa v 1.7. An interesting point is that numerous other species have a domain III outer ring aspartate instead of isoleucine, thus screening of Na v 1.7 modulators for human use that should use only hNa v 1.7. KIIIA has been shown previously to have analgesic behavior (Zhang et al., 2007) . Further honing KIIIA targeting toward hNa v 1.7 poses a challenge, in that two substitutions that were found to enhance this targeting (H12A and R14A) substantially reduce KIIIA affinity.
Changes in pH in disease states are well documented. During ischemia, a drop of almost 1 pH unit has been observed (Kraig et al., 1983) , and neuroprotective action of sodium channel blockers has been demonstrated (Carter et al., 2000) . Thus, blocking toxins, whose affinity increases as pH decreases, may be well suited to combat such disease states.
